BOCA RATON, Fla., Feb. 9, 2015 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce that it has opened a new plasma collection center. The state-of-the-art, 15,000 square foot facility located at 113 Yopp Road, Jacksonville, North Carolina, is BPC's second plasma center in Jacksonville, and officially opened its doors for business on February 3, 2015.
"We continue to expand our U.S. plasma collection operations to better serve the thousands of patients world-wide who rely on plasma based therapies," said Jordan Siegel, BPC's Chief Executive Officer.
The plasma donated at Biotest Plasma Centers is used to manufacture critical care therapies that treat life-threatening disorders in a variety of therapeutic areas, such as BPC's BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] and Nabi-HB® [Hepatitis B Immune Globulin (Human)].
BPC expects to add more than 50 jobs to Jacksonville's local economy and currently has career opportunities available for Licensed Practical Nurses/Registered Nurses, phlebotomists and various other positions. In addition to supporting the local economy through employment opportunities, the center is actively recruiting plasma donors.
About Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals Corporation, a wholly owned subsidiary of Biotest AG, a German global provider of plasma therapies, researches, develops and manufactures biotherapeutic products with a specialization in immunology and hematology. BPC is a leader in the collection of source plasma and is currently involved in the development of plasma protein products in the field of Primary Immune Deficiency (PID) and various hyperimmune (IG) products. The Company owns and manages seventeen plasmapheresis centers across the United States and a state-of-the-art manufacturing facility in Boca Raton, Florida. The Company employs more than 900 people in the U.S. To learn more about Biotest Pharmaceuticals and our Plasma Centers and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.
SOURCE Biotest Pharmaceuticals Corporation